Vanoli M, Daina E, Salvarani C, Sabbadini M G, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G
IRCCS Ospedale Maggiore, Milan, Italy.
Arthritis Rheum. 2005 Feb 15;53(1):100-7. doi: 10.1002/art.20922.
Takayasu's arteritis (TA) is a rare vasculitis. The Italian Takayasu's Arteritis study group was established with the aim to describe a large cohort of patients.
Data were collected by means of an ad hoc form. Demographic information, clinical history, vascular findings, treatment, risk factors, and comorbidities were analyzed.
Data of 104 patients were collected. The median delay in diagnosis was 15.5 months (range 0-325 months). Age at onset <15 years was associated with a higher probability, whereas elevated erythrocyte sedimentation rate with a lower probability, of a delay in diagnosis. The majority of patients experienced nonspecific signs and symptoms indicative of an inflammatory disease in the early phase. Among vascular involvement, stenosis was the most frequent lesion, being present in 93% of patients, followed by occlusion (57%), dilatation (16%), and aneurysm (7%). Glucocorticoids were the mainstay of treatment in our series; however, treatment with cytotoxic agents was required in about half of the patients. Fifty-two patients underwent at least 1 surgical procedure. The main indications for intervention were renal vascular hypertension, cerebral hypoperfusion, and limb claudication.
As with many rare diseases, delay in diagnosis is an important issue for patients with TA. The increasing occurrence of vascular lesions along with the disease progression put to question the long-term effectiveness of contemporary treatment. These data may be helpful in increasing physicians' awareness to prevent diagnosis delay, update guidelines, and plan future research projects.
高安动脉炎(TA)是一种罕见的血管炎。意大利高安动脉炎研究组旨在描述一大群患者。
通过专门设计的表格收集数据。分析人口统计学信息、临床病史、血管检查结果、治疗情况、危险因素和合并症。
收集了104例患者的数据。诊断延迟的中位数为15.5个月(范围0 - 325个月)。发病年龄<15岁与诊断延迟的可能性较高相关,而红细胞沉降率升高与诊断延迟的可能性较低相关。大多数患者在疾病早期出现提示炎症性疾病的非特异性体征和症状。在血管受累方面,狭窄是最常见的病变,93%的患者存在,其次是闭塞(57%)、扩张(16%)和动脉瘤(7%)。糖皮质激素是我们系列研究中治疗的主要药物;然而,约一半的患者需要细胞毒性药物治疗。52例患者至少接受了1次外科手术。干预的主要指征是肾血管性高血压、脑灌注不足和肢体间歇性跛行。
与许多罕见疾病一样,诊断延迟是TA患者的一个重要问题。随着疾病进展,血管病变的发生率不断增加,这对当代治疗的长期有效性提出了质疑。这些数据可能有助于提高医生对预防诊断延迟的认识、更新指南并规划未来的研究项目。